Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
32.90
+1.96 (6.33%)
At close: Jun 15, 2026, 4:00 PM EDT
32.88
-0.02 (-0.06%)
After-hours: Jun 15, 2026, 7:59 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $4.76 billion as of June 15, 2026. Its market cap has increased by 1,877.65% in one year.
Market Cap
4.76B
Enterprise Value
4.41B
1-Year Change
1,877.65%
Ranking
Category
Stock Price
$32.90
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $4.76B, an increase of 2,944.61%. That is a compound annual growth rate of 93.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 4.76B | 298.82% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 5.12B |
| Caris Life Sciences | 5.08B |
| Xenon Pharmaceuticals | 5.04B |
| Travere Therapeutics | 4.84B |
| CRISPR Therapeutics AG | 4.80B |
| Dianthus Therapeutics | 4.49B |
| Erasca | 4.37B |
| Celcuity | 4.32B |